Determinants of maternal triglycerides in women with gestational diabetes mellitus in themetformin in gestational diabetes (MiG) study

Diabetes Care

Volumn 36, Issue 7, 2013, Pages 1941-1946

  Barrett, Helen L ^a,b,c   Nitert, Marloes Dekker ^b,c   Jones, Lee ^d   O'Rourke, Peter ^d   Lust, Karin ^b,c   Gatford, Kathryn L ^e   De Blasio, Miles J ^e   Coat, Suzette ^e   Owens, Julie A ^e   Hague, William M ^e   McIntyre, H David ^c,f   Callaway, Leonie ^b,c   Rowan, Janet ^g  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF ADELAIDE   (Australia)

^f MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASIAN; BEHAVIOR CHANGE; CAUCASIAN; DIET RESTRICTION; ETHNICITY; FEEDING BEHAVIOR; FEMALE; GESTATIONAL AGE; GLYCEMIC CONTROL; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PACIFIC ISLANDER; PREGNANCY; PREGNANCY DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL MODEL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; DIABETES, GESTATIONAL; FASTING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; METFORMIN; PREGNANCY; TRIGLYCERIDES;

EID: 84885996706     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2132     Document Type: Article

References (39)

1. Herrera E, Amusquivar E, López-Soldado I, Ortega H. Maternal lipid metabolism and placental lipid transfer. Horm Res 2006;65(Suppl. 3):59-64
2. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002; 87:4231-4237
3. Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 2006;113:379-386
4. Koukkou E, Watts GF, Lowy C. Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J Clin Pathol 1996;49:634-637
5. Rizzo M, Berneis K, Altinova AE, et al. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. DiabetMed 2008;25: 1406-1411
6. Sobki SH, Al-Senaidy AM, Al-Shammari TA, Inam SS, Al-Gwiser AA, Bukhari SA. Impact of gestational diabetes on lipid profiling and indices of oxidative stress in maternal and cord plasma. Saudi Med J 2004;25:876-880
7. Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 2003;189:1698-1704
8. Schaefer-Graf UM, Graf K, Kulbacka I, et al. Maternal lipids as strong determinants of fetal environment and growth in pregnancies with gestational diabetes mellitus. Diabetes Care 2008;31:1858-1863
9. Di Cianni G, Miccoli R, Volpe L, et al. Maternal triglyceriDe levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005;22: 21-25
10. Son GH, Kwon JY, Kim YH, Park YW. Maternal serum triglycerides as predictive factors for large-for-gestational age newborns in women with gestational diabetes mellitus. Acta Obstet Gynecol Scand 2010;89:700-704
11. Hue L, Taegtmeyer H. The Randle cycle revisited: a new head for an old hat. Am J Physiol Endocrinol Metab 2009;297: E578-E591
12. Semenkovich CF, Wims M, Noe L, Etienne J, Chan L. Insulin regulation of lipoprotein lipase activity in 3T3-L1 adipocytes is mediated at posttranscriptional and posttranslational levels. J Biol Chem 1989;264:9030-9038
13. Wulffelé MG, Kooy A, De Zeeuw D, Stehouwer CD, Gansevoort RT. The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med 2004;256:1-14
14. Reaven GM, Johnston P, Hollenbeck CB, et al. Combined metformin-sulfonylurea treatment of patients with noninsulindependent diabetes in fair to poor glycemic control. J Clin Endocrinol Metab 1992;74:1020-1026
15. Ohira M, Miyashita Y, Ebisuno M, et al. Effect of metformin on serum lipoprotein lipase mass levels and LDL particle size in type 2 diabetes mellitus patients. Diabetes Res Clin Pract 2007;78:34-41
16. Abbasi F, Carantoni M, Chen YD, Reaven GM. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care 1998; 21:1301-1305
17. Barrett HL, Gatford KL, Houda CM, et al. Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the Metformin in Gestational Diabetes (MiG) trial: responses to maternal metformin versus insulin treatment. Diabetes Care 2013;36:529-536
18. Rowan JA,HagueWM, Gao W, BattinMR, Moore MP; MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358:2003-2015
19. McElduff A, Cheung NW, McIntyre HD, et al.; Australasian Diabetes in Pregnancy Society. The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy. Med J Aust 2005;183:373-377
20. Schaefer-Graf UM, Meitzner K, Ortega- Senovilla H, et al. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med 2011;28:1053-1059
21. Toescu V, Nuttall SL, Martin U, et al. Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes. Clin Sci (Lond) 2004;106:93-98
22. Göbl CS, Handisurya A, Klein K, et al. Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects. Diabetes Care 2010;33:2071-2073
23. Larsson A, Palm M, Hansson LO, Axelsson O. Reference values for clinical chemistry tests during normal pregnancy. BJOG 2008;115:874-881
24. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011;50:14-27
25. Metzger BE, Lowe LP, Dyer AR, et al.; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008;358:1991-2002
26. Wulan SN, Westerterp KR, Plasqui G. Ethnic differences in body composition and the associated metabolic profile: a comparative study between Asians and Caucasians. Maturitas 2010;65:315-319
27. Sumner AE. Ethnic differences in triglyceriDe levels and high-density lipoprotein lead to underdiagnosis of the metabolic syndrome in black children and adults. J Pediatr 2009;155:e7-e11
28. Gasevic D, Frohlich J, Mancini GB, Lear SA. The association between triglyceriDe to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort. Metabolism 2012;61:583-589
29. Shand B, Elder P, Scott R, Poa N, Frampton CM. Comparison of plasma adiponectin levels in New Zealand Maori and Caucasian individuals. N Z Med J 2007;120: U2606
30. Gao H, Salim A, Lee J, Tai ES, Van DamRM. Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians? Int J Obes (Lond) 2012;36:1086-1093
31. Retnakaran R, Hanley AJ, Connelly PW, Sermer M, Zinman B. Ethnicity modifies the effect of obesity on insulin resistance in pregnancy: a comparison of Asian, South Asian, and Caucasian women. J Clin Endocrinol Metab 2006;91:93-97
32. Schreuder YJ, Hutten BA, Van Eijsden M, et al. Ethnic differences in maternal total cholesterol and triglyceriDe levels during pregnancy: the contribution of demographics, behavioural factors and clinical characteristics. Eur J Clin Nutr 2011;65: 580-589
33. Ahlin G, Chen L, Lazorova L, et al. Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions. Pharmacogenomics J 2011;11:400-411
34. Chen L, Pawlikowski B, Schlessinger A, et al. Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. Pharmacogenet Genomics 2010;20:687-699
35. Song IS, Shin HJ, Shim EJ, et al. Genetic variants of the organic cation transporter 2 influence the disposition of metformin. Clin Pharmacol Ther 2008;84:559-562
36. Katsiki N, Mikhailidis DP, Gotzamani- Psarrakou A, Didangelos TP, Yovos JG, Karamitsos DT. Effects of improving glycemiccontrol with insulin on leptin, adiponectin, ghrelin and neuropeptidey levels in patients with type 2 diabetes mellitus: a pilot study. Open Cardiovasc Med J 2011;5:136-147
37. Malhotra A, Scott PH, Scott J, Gee H, Wharton BA. Metabolic changes in Asian Muslim pregnant mothers observing the Ramadan fast in Britain. Br J Nutr 1989; 61:663-672
38. Knopp RH,Magee MS, Raisys V, Benedetti T.Metabolic effects of hypocaloric diets in management of gestational diabetes. Diabetes 1991;40(Suppl. 2):165-171
39. Nolan CJ. Improved glucose tolerance in gestational diabetic women on a low fat, high unrefined carbohydrate diet. Aust N Z J Obstet Gynaecol 1984;24:174-177